Plumbline Life Sciences Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
4
- Stock Symbol
-
222670
- Investments
-
1
- Share Price
-
$3.21
- (As of Thursday Closing)
Plumbline Life Sciences General Information
Description
Plumbline Life Sciences Inc is a bio-animal health company. The company provides Dog cancer treatment, such as pig DNA Therapy. It provides curing for animals and healing for humans.
Contact Information
Website
www.plsdna.comCorporate Office
- Room 1315, Songeui Multiplex Hall
- College of Medicine, The Catholic University of Korea, 222 Banpo-daero
- Seocho-gu, Seoul
- South Korea
Corporate Office
- Room 1315, Songeui Multiplex Hall
- College of Medicine, The Catholic University of Korea, 222 Banpo-daero
- Seocho-gu, Seoul
- South Korea
Plumbline Life Sciences Timeline
Plumbline Life Sciences Stock Performance
As of 19-Feb-2026, Plumbline Life Sciences’s stock price is $3.21. Its current market cap is $11M with 3.42M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.21 | $3.25 | $2.54 - $6.18 | $11M | 3.42M | 2.31K | -$0.50 |
Plumbline Life Sciences Financials Summary
As of 31-Dec-2025, Plumbline Life Sciences has a trailing 12-month revenue of $13.5K.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 |
|---|---|---|---|
| EV | 13,259 | 13,259 | |
| Revenue | 13 | 13 | |
| EBITDA | (733) | (733) | (1,002) |
| Net Income | (1,006) | (1,006) | (1,486) |
| Total Assets | 1,982 | 1,982 | 1,543 |
| Total Debt | 645 | 645 | 1,085 |
Plumbline Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Plumbline Life Sciences Patents
Plumbline Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3181812-A1 | African swine fever vaccine composition | Pending | 14-Apr-2020 | ||
| EP-4137506-A1 | African swine fever vaccine composition | Pending | 14-Apr-2020 | ||
| EP-4137506-A4 | African swine fever vaccine composition | Pending | 14-Apr-2020 | ||
| JP-2023522053-A | African swine fever vaccine composition | Active | 14-Apr-2020 | ||
| JP-7905103-B2 | African swine fever vaccine composition | Active | 14-Apr-2020 | A61P31/20 |
Plumbline Life Sciences Signals
Plumbline Life Sciences Acquisitions (1)
Plumbline Life Sciences’s most recent deal was a Merger/Acquisition with VGX Animal Health for . The deal was made on 27-May-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| VGX Animal Health | 27-May-2014 | Merger/Acquisition | Other Commercial Products |
Plumbline Life Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Plumbline Life Sciences FAQs
-
When was Plumbline Life Sciences founded?
Plumbline Life Sciences was founded in 2014.
-
Where is Plumbline Life Sciences headquartered?
Plumbline Life Sciences is headquartered in Seocho-gu, South Korea.
-
What is the size of Plumbline Life Sciences?
Plumbline Life Sciences has 4 total employees.
-
What industry is Plumbline Life Sciences in?
Plumbline Life Sciences’s primary industry is Other Commercial Services.
-
Is Plumbline Life Sciences a private or public company?
Plumbline Life Sciences is a Public company.
-
What is Plumbline Life Sciences’s stock symbol?
The ticker symbol for Plumbline Life Sciences is 222670.
-
What is the current stock price of Plumbline Life Sciences?
As of 19-Feb-2026 the stock price of Plumbline Life Sciences is $3.21.
-
What is the current market cap of Plumbline Life Sciences?
The current market capitalization of Plumbline Life Sciences is $11M.
-
What is Plumbline Life Sciences’s current revenue?
The trailing twelve month revenue for Plumbline Life Sciences is $13.5K.
-
What is Plumbline Life Sciences’s annual earnings per share (EPS)?
Plumbline Life Sciences’s EPS for 12 months was -$0.50.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process